All Stories

  1. Influence of Culture Among Users of Illegal Drugs: An Ethnographic Study
  2. Eating Behaviors during Pregnancy: A Cross-Sectional Study
  3. Post-Traumatic Psychological Experience of COVID-19 Survivors: A Descriptive Phenomenological Study
  4. Eating Behaviors during Pregnancy: A Cross-Sectional Study
  5. Support for Mandatory COVID-19 Vaccines for Children
  6. Burden of disease scenarios for 204 countries
  7. [Review Article] Drug Use Disorder and Coping Mechanisms Due to COVID-19 Lockdown Measures: A Cross-Sectional Survey
  8. Should we be concern about the Recent Avian Influenza Outbreaks?
  9. [Review Article] Drug Use Disorder and Coping Mechanisms Due to COVID-19 Pandemic Measures: A Cross-Sectional Survey
  10. Drug Use Disorder and Coping Mechanisms Due to COVID-19 Pandemic Measures: A Cross-Sectional Survey
  11. Elimination of Mother-to-Child Transmission of Hepatitis B Virus in Gulf Cooperation Council Countries: Current Status and Future Prospects
  12. Assessing Healthcare Providers' Preparedness for Managing COVID-19 Patients: A Mixed-Methods Study
  13. Reply to Hamzavi et al. Comment on “Islam et al. Helminth Parasites among Rodents in the Middle East Countries: A Systematic Review and Meta-Analysis. Animals 2020, 10, 2342”
  14. Non-pharmaceutical Interventions (NPIs) are strategies that individuals and communities
  15. Spontaneous remission of angioimmunoblastic T‑cell lymphoma
  16. Herpes Zoster Burden of Disease and Clinical Management in Turkey: A Comprehensive Literature Review
  17. Antimicrobial Stewardship Opportunities: An Example from Oman
  18. The Progress Towards National Malaria Elimination: The Experience of Oman
  19. Forecasting smoking deaths to 2050: a forecasting analysis for the global burden of disease study
  20. This review reports on the recent epidemiology of invasive meningococcal disease (IMD) the GCC
  21. Influenza Vaccine hesitancy in EMR
  22. An outbreak of human monkeypox (Hmpox) in multiple non-endemic countries
  23. Epidemiology of Varicella Zoster Virus and Herpes Zoster Virus in Gulf Cooperation Council Countries
  24. Oman's COVID-19 publication trends: A cross-sectional bibliometric study
  25. The Impact of Demographic, Clinical Characteristics and the Various COVID-19 Variant Types
  26. This study aimed to assess the acceptance of COVID-19 vaccine booster doses in the countries
  27. The Role of Psychological Factors and Vaccine Conspiracy Beliefs in Influenza Vaccine Hesitancy and Uptake among Jordanian Healthcare Workers during the COVID-19 Pandemic
  28. Assessing COVID-19 Vaccine’s Acceptability Amongst Health Care Workers in Oman
  29. Alarming Antibiotic Resistance in Pediatric Oncology Patients
  30. Knowledge, Attitude, and Acceptability of COVID-19 Vaccine in Oman
  31. Improving the process of employee recognition: An exploratory study
  32. Integrated Care for the Elderly in the Primary Health Care setting Oman: The Scope and Experience
  33. Weaning Practices Impact Factors and Outcomes an experiance from Oman
  34. A Systematic Review of Influenza Epidemiology and Surveillance in the Eastern Mediterranean and North African Region
  35. Hospitalized Patients with Moderate versus Severe COVID-19 Infection
  36. Our paper illustrated the importance of influenza vaccination among DM
  37. Living-Donor Liver Transplant in Oman: A Quantitative Cross-Sectional Study of Donors’ Experiences and Challenges
  38. Epidemiological Risk Factors for Acquiring Severe COVID-19
  39. This a work done by our countries
  40. Epidemiological Characteristics of Hepatitis B Positive Patients in Oman
  41. Epidemiological Characteristics of 69,382 COVID-19 Patients in Oman
  42. An Innovative Communication Approach to Mitigate Suffering Among COVID-19 Patients and Their Families: An Experience From Oman
  43. Role of primary healthcare in the response to COVID-19
  44. Levels of Physical Activity,
  45. Community Participation Approaches for Effective National COVID-19 Pandemic Preparedness and Response: An Experience From Oman
  46. Efforts for measles elimination in the Gulf Cooperation Council countries 2015–2019: A review
  47. Helminth Parasites among Rodents in the Middle East Countries
  48. Addressing Influenza Vaccination in MENA Region during the COVID-19 Pandemic: Decreasing the Effects of the Collision
  49. Influenza Vaccination Hesitancy among Healthcare Workers in Oman
  50. Preparing the Community for an upcoming Vaccine Against COVID-19
  51. Pneumococcal Meningitis Among Children in the Post-13-Valent Pneumococcal Conjugate Vaccine Era: Three Case Reports
  52. Trends and risk factors of mortality and disability adjusted life years for chronic respiratory diseases from 1990 to 2017: systematic analysis for the Global Burden of Disease Study 2017
  53. COVID 19 in Oman
  54. One Health operational framework for action for the Eastern Mediterranean Region
  55. The Omani experiences in presenting the first COVID 19 cases
  56. Oman, MERS-CoV
  57. This manuscript provided information on Health promotion strategy as part of Vision 2050 in Oman
  58. This paper gives over the situation of WPV globally and specifically in Oman.
  59. Assessment of Key Performance Indicators of the Primary Health Care in Oman
  60. Zoonotic Diseases in Oman: Successes, Challenges, and Future Directions
  61. assess the impact of non-pharmaceutical interventions on the COVID-19 epidemic in Oman
  62. Hepatitis B Elimination in GHC states
  63. MERS-Cov in Oman
  64. Dengue outbreak in Oman
  65. Influenza surveillance in MENA countries
  66. EMARIS report
  67. Successes and Challenges of HIV/AIDS Program in Oman: 1984–2015
  68. TB in Oman
  69. Assessment of hepatitis B immunization programme among school students in Qatar
  70. TB Elimination in GHC states
  71. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 2006 to 2016: A systematic analysis for the Global Burden of Disease study.
  72. Assessment of safe injection practices in health facilities in Oman
  73. Pertussis control
  74. The manuscript provided the leprosy situation in Oman and the way forward
  75. Progress towards measles, rubella and congenital rubella syndrome elimination: Oman experience
  76. Early Clinical Manifestations of CRS
  77. Late Clinical Manifestations of Congenital Rubella Syndrome
  78. Epidemiology of Pandemic H1N1 in Oman and Public Health Response, 2009
  79. Dengue epidemiological trend in Oman: a 13-year national surveillance and strategic proposition of imported cases
  80. Cost effectiveness of a pentavalent rotavirus vaccine in Oman
  81. Molecular Epidemiology and Genotyping of Hepatitis B Virus of HBsAg-Positive Patients in Oman
  82. HPV epidemiological situation in EMR
  83. Progress toward Elimination of Hepatitis B Virus Transmission in Oman: Impact of Hepatitis B Vaccination
  84. Epidemiology of invasive pneumococcal infection among hospitalized children aged less than 5 years in Oman
  85. Absence of lymphatic filariasis infection among secondary-school children
  86. The National Committee for Vaccines Regulation and Surveillance of Vaccine-Preventable Diseases in the Sultanate of Oman: Evidence-based approach and consensus decision-making
  87. Life expectancy and years of life lost in chronic obstructive pulmonary disease: Findings from the NHANES III Follow-up Study
  88. ocular manifestations of congenital rubella syndrome
  89. Poliomyelitis in Oman. I. The last outbreak?
  90. Poliomyelitis in Oman. II. Toward eradication